CLINICAL_TRIALS trial_result · 2014-06-12

Clinical Trial Update: Flibanserin for the Treatment of Hypoactive Sexual Desire Disorder in Postmenopausal Women [Phase 3]

Phase 3 clinical trial evaluating flibanserin for hypoactive sexual desire disorder in postmenopausal women has completed and results were posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Sprout Pharmaceuticals, Inc | Conditions: Sexual Dysfunctions, Psychological | Phase 3 | Status: COMPLETED | Results posted: 2014-06-12